Ticker Details
Fulcrum Therapeutics, Inc.
IPO Date:	July 15, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$239.21M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.42 | 4.45%
Avg Daily Range (30 D):	$0.20 | 4.03%
Avg Daily Range (90 D):	$0.25 | 3.81%

Institutional Daily Volume
Avg Daily Volume:	.73M
Avg Daily Volume (30 D):	3.69M
Avg Daily Volume (90 D):	1.76M

Trade Size
Avg Trade Size (Sh.):	107
Avg Trade Size (Sh.) (30 D):	204
Avg Trade Size (Sh.) (90 D):	137

Institutional Trades
Total Institutional Trades:	926
Avg Institutional Trade:	$1.44M
Avg Institutional Trade (30 D):	$1.23M
Avg Institutional Trade (90 D):	$1.2M
Avg Institutional Trade Volume:	.18M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.51M
Avg Closing Trade (30 D):	$1.31M
Avg Closing Trade (90 D):	$1.25M
Avg Closing Volume:	181.87K

News

Jun 2, 2026 @ 4:56 PM Fulcrum Therapeutics, Inc. Shareholders Are Encour... Source: Johnson Fistel, Pllp

Jun 2, 2026 @ 5:50 AM FULC Stock Crashes After Hours: What Investors Nee... Source: Tanya Rawat

Apr 27, 2026 @ 11:00 AM Fulcrum Therapeutics Announces Recent Business Hig... Source: Not Specified

Mar 19, 2026 @ 12:00 PM MedicAlert Foundation, Sickle Cell Disease Associa... Source: Na

Feb 24, 2026 @ 12:00 PM Fulcrum Therapeutics Announces Positive 12-Week Re... Source: Na

Financials
	TTM	Q1 2026	Q2 2025
Basic EPS		$-.25	$-.28
Diluted EPS		$-.25	$-.28
Revenue		$M	$M
Gross Profit
Net Income / Loss		$-18.89M	$-17.3M
Operating Income / Loss		$-22.19M	$-19.82M
Cost of Revenue
Net Cash Flow		$-147.27M	$-15.62M
PE Ratio